NCT07368309 2026-01-26
Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal Cancer
Renmin Hospital of Wuhan University
Completed
Clinical Trials
37 trialsNCT00243633 2025-12-23
Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)
University Hospital, Tours
Phase NA Completed
NCT03071458 2025-12-10
MUTHEC
Institut National de la Santé Et de la Recherche Médicale, France
Completed
NCT05178303 2025-05-16
SB-1121
Trieu, Nguyen Thi, M.D.
Phase 4 Completed
NCT03507140 2025-04-20
BIM-LT
University Hospital, Grenoble
Completed
NCT03311152 2025-01-14
SEPT9-CROSS
Central Hospital, Nancy, France
Phase NA Completed
NCT04802954 2024-12-18
STARHE
IHU Strasbourg
Phase NA Completed
NCT06683820 2024-12-05
Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques
Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00059267 2024-11-15
Prevention of Recurrent Hepatitis B After Liver Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
NCT06420791 2024-05-20
The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in China
Zhejiang University
Completed
NCT02273362 2024-03-26
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT04248816 2023-02-14
Hepatocellular Carcinoma Surveillance in Cirrhotics
University of Pennsylvania
Phase NA Completed
NCT04375670 2022-08-09
COVID19-FOIE National Observatory
Assistance Publique - Hôpitaux de Paris
Completed
NCT01798173 2022-04-21
CIRCE
Centre Hospitalier Universitaire Dijon
Phase NA Completed
NCT02224456 2022-02-14
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
GlaxoSmithKline
Phase 4 Completed
NCT01387503 2021-10-11
Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Completed
NCT04994548 2021-08-06
Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension
Central Hospital, Nancy, France
Completed
NCT02774161 2021-08-03
B-mode Ultrasound Imaging in Detecting Early Liver Cancer
Stanford University
Phase NA Completed
NCT01198704 2020-11-20
EFAPRE
Assistance Publique - Hôpitaux de Paris
Completed
NCT01264705 2020-11-12
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT02129829 2020-09-28
WATCH
Imperial College London
Completed
NCT02151864 2019-03-05
LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis
University of California, San Diego
Phase 1 Completed
NCT03706846 2018-10-16
GASTROPREP
Centre Hospitalier Universitaire de Besancon
Phase NA Completed
NCT02321202 2018-08-22
Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer
Huazhong University of Science and Technology
Phase 4 Completed
NCT00096733 2017-08-29
A2ALL-1
Arbor Research Collaborative for Health
Completed
NCT00629421 2017-08-22
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
Kaohsiung Medical University Chung-Ho Memorial Hospital
Completed
NCT00706576 2017-08-02
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
University of Missouri-Columbia
Phase 1 Completed
NCT00122135 2015-12-14
Aim3
VA Office of Research and Development
Phase NA Completed
NCT02540382 2015-09-03
Comparison of Covered and Bare Stent in TIPS
Beijing Shijitan Hospital, Capital Medical University
Phase NA Completed
NCT01082419 2014-11-07
NARFI
University Hospital, Bordeaux
Phase NA Completed
NCT01657695 2012-10-02
UniRer
University of Modena and Reggio Emilia
Completed
NCT00802555 2012-07-12
Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed
NCT01387061 2011-09-20
Resection for Multiple Hepatocellular Carcinomas (HCC)
University of Milan
Phase NA Completed
NCT00190385 2011-02-25
Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT00502086 2011-02-11
Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.
Catalysis SL
Phase 3 Completed
NCT00883454 2009-04-17
Estimation of Functional Liver Reserve Using Cholinesterases
University of Milan
Completed